Clinical trial
Treatment of Residual Myopic Refraction After 6 Months on Pseudophakic Patients Using Relex-Smile
NCT04693663 is registered in ClinicalTrials.gov with Eye Hospital Pristina Kosovo as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Treatment of Residual Myopic Refraction After 6 Months on Pseudophakic Patients Using Relex-Smile
- Lead sponsor
- Eye Hospital Pristina Kosovo
- Phase
- Not applicable
- Overall status
- Enrolling by invitation
- Start date
- June 1, 2017
- Completion date
- June 1, 2027
- Enrollment
- 20 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.